Australia’s Cannabiz reports…
BREAKING NEWS: The Therapeutic Goods Administration (TGA) will be conducting another public consultation on overhauling the standards required for imported medicinal cannabis before the end of the year, with changes expected in March 2022.
TGA director of experimental products Petra Bismire told attendees at a webinar on changes to sponsor requirements for supplying unapproved medicinal cannabis products in Australia that while GMP requirements remain unchanged at present, a level playing field can be expected next year.
She said: “GMP requirements at present remain the same, but we held a public consultation in January regarding the issue and changes will be brought into place. They are expected to be effective from approximately March next year [and] level the playing field to require GMP for imported products.
“There’s also going to be another public consultation later this year to outline further detail.”
Read their full article at https://www.cannabiz.com.au/tga-tips-level-playing-field-on-imports-by-march-next-year/?utm_medium=email&utm_campaign=Cannabiz%20newsletter%20251121&utm_content=Cannabiz%20newsletter%20251121+CID_e4643053c13a19b616c19e4ddd2ceedd&utm_source=CampaignMonitor&utm_term=TGA%20tips%20level%20playing%20field%20on%20imports%20by%20early%20next%20year